Snapshot
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
The Asia-Pacific Pneumococcal Vaccine market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pneumococcal Vaccine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
PPSV 23
PCV 7/13
PCV 10



Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
MSD
Sanofipasteur
CDIBP
Pfizer
GSK
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Infants
Children (2-10)
Person (10-64)
The old (≥65)
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
China
Japan & Korea
India
Southeast Asia
Oceania